Archive · 25 Jul 2025
Delhi High Court to Govt: Ensure Recombinant Factor Availability
Imagine you have a medical condition called hemophilia, which means your blood doesn't clot well.
The best medicine for it, like a special injection, is called recombinant factor.
For a while, a patient named Mukul couldn't get this medicine easily in Delhi, so he had to travel to other cities.
He went to court.
The court said, "If doctors say you need this medicine, you should get it!"
The government promised to make sure there's enough of it available in the future.
The patient also pointed out other problems, like a lack of special care centers for people with hemophilia.
Delhi High Court addressed the Delhi government regarding recombinant factor availability.
A hemophilia patient, Mukul Gandhi, faced challenges accessing the recombinant factor in Delhi.
The Delhi government assured the court it would ensure adequate recombinant factor stocks.
The court emphasized that if a doctor prescribes recombinant factor, it should be available.
The patient highlighted broader systemic issues like lack of hemophilia daycare and hematologists.
- Who
- The Delhi High Court, the Delhi government, and hemophilia patients like Mukul Gandhi.
- What
- The Delhi High Court addressed the availability of recombinant factor for hemophilia patients.
- When
- The Delhi government assured the court on July 14th.
- Where
- Delhi
- Why
- To ensure patients have access to prescribed medication and to address systemic issues in care.
Patient's Perspective
Government's Perspective
Efficacy of Recombinant Factor
Patient's Perspective
Recombinant factor is preferred and should be readily available.
Government's Perspective
Experts suggest there is no difference in efficacy between recombinant and plasma-derived factors.
- Patient
- Mukul Gandhi
- Condition
- Hemophilia
- Treatment
- Recombinant Factor
- Court
- Delhi High Court
- Government Response
- Assured adequate stock
- Patient's Disability
- 69%